pharma · Postoperative Pain · Pain · PCRX
Pacira Ireland
Pacira Ireland Limited
Pacira Ireland patent portfolio — 57 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Ranelagh, IE
- Founded
- 2007
- Employees
- 7
- Programs
- 100
- Drugs
- 32
- Patents
- 57
Pacira Ireland patents
57 pharmaceutical patents indexed for Pacira Ireland. 0 expire within 24 months.
Pacira Ireland has 57 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 9737482
Method for formulating large diameter synthetic membrane vesicles
granted -
US 9737483
Method for formulating large diameter synthetic membrane vesicles
granted -
US 9730892
Method for formulating large diameter synthetic membrane vesicles
granted -
US 9724302
Method for formulating large diameter synthetic membrane vesicles
granted -
US 9585838
Production of multivesicular liposomes
granted -
US 9205052
Sustained-release liposomal anesthetic compositions
granted -
US 9192575
Sustained-release liposomal anesthetic compositions
granted -
US 8834921
Sustained-release liposomal anesthetic compositions
granted -
US 8182835
Sustained-release liposomal anesthetic compositions
granted
Frequently asked questions
How many patents does Pacira Ireland have?
57 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Pacira Ireland patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.